4.3 Article

Solid-state 17O NMR spectroscopy of a phospholemman transmembrane domain protein:: Implications for the limits of detecting dilute 170 sites in biomaterials

Journal

SOLID STATE NUCLEAR MAGNETIC RESONANCE
Volume 33, Issue 4, Pages 72-75

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ssnmr.2008.04.003

Keywords

O-17 MAS; dilute O-17 content; transmembrane protein; phospholemman

Funding

  1. Biotechnology and Biological Sciences Research Council [BB/C000471/1] Funding Source: Medline
  2. Biotechnology and Biological Sciences Research Council [BB/C000471/1] Funding Source: researchfish

Ask authors/readers for more resources

The O-17-'diluted' glycine-14 sites in a phospholemman (PLM) transmembrane domain protein are characterized by solid-state O-17 NMR spectroscopy. The PLM transmembrane domain is an a-helical tetramer unit of four 28-residue peptides and is rigidly embedded in a bilayer where each a-helix has an average tilt of 7.3 degrees against the membrane normal. The PLM sample investigated here consists of a high lipid/peptide molar ratio (25: 1) with one glycine residue in each helix enriched to < 40% O-17; thus, this is a very dilute 17 -sample and is the most dilute O-17-membrane protein to date to be characterized by solid-state 17 0 NMR spectroscopy. Based on the spectral analysis of O-17 magic angle spinning (MAS) at 14.1 and 18.8T, the PLM transmembrane domain protein consists of multiple crystallographic gly14 sites, suggesting that the tetramer protein is an asymmetric unit with either C-2- or C-1-rotational symmetry along the bilayer normal. (c) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available